When budgets are tight, there are better options than colonoscopies for colorectal cancer screening
- PMID: 20671020
- DOI: 10.1377/hlthaff.2008.0898
When budgets are tight, there are better options than colonoscopies for colorectal cancer screening
Abstract
A critical challenge facing cancer screening programs, particularly those aimed at uninsured people with low incomes, is choosing the screening test that makes the most efficient use of limited budgets. For colorectal cancer screening, there is growing momentum to use colonoscopy, which is an expensive test. In this study, we modeled scenarios to assess whether the use of fecal occult blood tests or colonoscopy provides the most benefit under conditions of budget constraints. We found that although colonoscopy is more accurate, under most scenarios, fecal occult blood tests would result in more individuals' getting screened, with more life-years gained.
Similar articles
-
Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.Dis Colon Rectum. 2011 Jul;54(7):876-86. doi: 10.1007/DCR.0b013e31820fd2bc. Dis Colon Rectum. 2011. PMID: 21654256
-
Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1079-83. doi: 10.1097/01.meg.0000231754.35340.fa. Eur J Gastroenterol Hepatol. 2006. PMID: 16957514
-
Fecal occult blood testing when colonoscopy capacity is limited.J Natl Cancer Inst. 2011 Dec 7;103(23):1741-51. doi: 10.1093/jnci/djr385. Epub 2011 Nov 9. J Natl Cancer Inst. 2011. PMID: 22076285
-
Screening for colorectal cancer.Tech Coloproctol. 2004 Nov;8 Suppl 1:s10-3. doi: 10.1007/s10151-004-0098-9. Tech Coloproctol. 2004. PMID: 15655587 Review.
-
[Individual screening for colorectal cancer: which strategy for which patient?].Rev Med Brux. 2001 Sep;22(4):A203-9. Rev Med Brux. 2001. PMID: 11680174 Review. French.
Cited by
-
Modifications in Primary Care Clinics to Continue Colorectal Cancer Screening Promotion During the COVID-19 Pandemic.J Community Health. 2023 Feb;48(1):113-126. doi: 10.1007/s10900-022-01154-9. Epub 2022 Oct 29. J Community Health. 2023. PMID: 36308666 Free PMC article.
-
Assessing the impact of multicomponent interventions on colorectal cancer screening through simulation: What would it take to reach national screening targets in North Carolina?Prev Med. 2022 Sep;162:107126. doi: 10.1016/j.ypmed.2022.107126. Epub 2022 Jul 3. Prev Med. 2022. PMID: 35787844 Free PMC article.
-
Role of an Implementation Economics Analysis in Providing the Evidence Base for Increasing Colorectal Cancer Screening.Prev Chronic Dis. 2020 Jun 25;17:E46. doi: 10.5888/pcd17.190407. Prev Chronic Dis. 2020. PMID: 32584756 Free PMC article.
-
Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.Cancer Med. 2019 Dec;8(17):7408-7418. doi: 10.1002/cam4.2604. Epub 2019 Oct 21. Cancer Med. 2019. PMID: 31637870 Free PMC article.
-
Efficacy and safety of celecoxib on the incidence of recurrent colorectal adenomas: a systematic review and meta-analysis.Cancer Manag Res. 2019 Jan 9;11:561-571. doi: 10.2147/CMAR.S180261. eCollection 2019. Cancer Manag Res. 2019. PMID: 30666154 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
